Moreover, in the absence of an increase in TMB, mutations of the SETDB1 gene in MPM (which have not been found in our patient’s tumor) also appear to be a potential marker of sensitivity to ICI, as observed in the patients reported by Becker et al. The gene discussed is SETDB1; the disease is neoplasm.